Stay updated on Pembrolizumab in Advanced Head and Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Head and Neck Clinical Trial page
- Check6 days agoChange DetectedAn NIH-wide banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence.” The site revision number changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe NCT03765918 study record page now shows a 403 Forbidden error, replacing the previous content and navigation with an error page. This prevents users from viewing the study details and related information.SummaryDifference21%

- Check41 days agoChange DetectedThe revision tag on the page was updated from v3.6.6 to v3.7.0, signaling a new version of the page/document. This reflects an update to the page's metadata rather than to substantive content.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision: v3.6.6 replaces v3.6.5. This update reflects a software/version bump with no visible changes to the page's content or layout.SummaryDifference0.0%

- Check62 days agoChange DetectedA funding attribution for 2017 NIH grant/contract has been added to the study details, indicating NIH support for the trial.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Advanced Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.